Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Mar. 29, 2022 | Jun. 30, 2021 | |
Document Information Line Items | |||
Entity Registrant Name | FAST ACQUISITION CORP. II | ||
Trading Symbol | FZT | ||
Document Type | 10-K | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Public Float | $ 217,445,459 | ||
Amendment Flag | false | ||
Entity Central Index Key | 0001839824 | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Well-known Seasoned Issuer | No | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Shell Company | true | ||
Entity Ex Transition Period | false | ||
ICFR Auditor Attestation Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity File Number | 001-40214 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 86-1258014 | ||
Entity Address, Address Line One | 109 Old Branchville Road | ||
Entity Address, City or Town | Ridgefield | ||
Entity Address, State or Province | CT | ||
Entity Address, Postal Zip Code | 06877 | ||
City Area Code | (201) | ||
Local Phone Number | 956-1969 | ||
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | ||
Security Exchange Name | NYSE | ||
Entity Interactive Data Current | Yes | ||
Auditor Name | WithumSmith+Brown, PC | ||
Auditor Location | New York, New York | ||
Auditor Firm ID | 100 | ||
Class A Common stock | |||
Document Information Line Items | |||
Entity Common Stock, Shares Outstanding | 22,233,687 | ||
Class B Common stock | |||
Document Information Line Items | |||
Entity Common Stock, Shares Outstanding | 5,558,422 |
Balance Sheet
Balance Sheet | Dec. 31, 2021USD ($) |
Current assets: | |
Cash | $ 584,216 |
Prepaid expenses | 378,247 |
Total current assets | 962,463 |
Cash and Investment held in Trust Account | 222,380,591 |
Total Assets | 223,343,054 |
Current liabilities: | |
Accounts payable | 165,909 |
Accrued expenses | 141,216 |
Franchise tax payable | 200,000 |
Due to related party | 15,000 |
Total current liabilities | 522,125 |
Derivative warrant liabilities | 8,660,890 |
Deferred underwriting commissions in connection with the initial public offering | 7,781,790 |
Total Liabilities | 16,964,805 |
Commitments and Contingencies | |
Class A common stock; 22,233,687 shares subject to possible redemption at redemption value of $10.00 per share | 222,336,870 |
Stockholders’ Deficit: | |
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; no non-redeemable shares issued or outstanding | |
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 5,558,422 shares issued and outstanding | 556 |
Additional paid-in capital | |
Accumulated deficit | (15,959,177) |
Total stockholders’ deficit | (15,958,621) |
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit | $ 223,343,054 |
Balance Sheet (Parentheticals)
Balance Sheet (Parentheticals) | Dec. 31, 2021$ / sharesshares |
Preferred stock par value (in Dollars per share) | $ / shares | $ 0.0001 |
Preferred stock, shares authorized | 1,000,000 |
Preferred stock, shares issued | |
Preferred stock, shares outstanding | |
Class A Common Stock | |
Shares subject to possible redemption | 22,233,687 |
Subject to possible redemption, per share (in Dollars per share) | $ / shares | $ 10 |
Common stock, par value (in Dollars per share) | $ / shares | $ 0.0001 |
Common stock, shares authorized | 380,000,000 |
Class B Common Stock | |
Common stock, par value (in Dollars per share) | $ / shares | $ 0.0001 |
Common stock, shares authorized | 20,000,000 |
Common stock, shares issued | 5,558,422 |
Common stock, shares outstanding | 5,558,422 |
Statement of Operations
Statement of Operations | 12 Months Ended |
Dec. 31, 2021USD ($)$ / sharesshares | |
General and administrative costs | $ 675,284 |
Administrative expenses - related party | 150,000 |
Franchise tax expense | 200,450 |
Loss from operations | (1,025,734) |
Other income (expense): | |
Change in fair value of derivative warrant liabilities | 4,940,730 |
Offering cost - derivative warrant liabilities | (455,643) |
Net income from investments held in Trust Account | 43,721 |
Net income | $ 3,503,074 |
Class A Common Stock | |
Other income (expense): | |
Weighted average shares outstanding of Class A common stock, basic and diluted (in Shares) | shares | 17,603,478 |
Basic and diluted net income per share, Class A common stock (in Dollars per share) | $ / shares | $ 0.15 |
Class B Common Stock | |
Other income (expense): | |
Weighted average shares outstanding of Class A common stock, basic and diluted (in Shares) | shares | 5,558,422 |
Weighted average shares outstanding of Class B common stock, basic (in Shares) | shares | 5,345,604 |
Weighted average shares outstanding of Class B common stock, diluted (in Shares) | shares | 5,558,422 |
Basic and diluted net income per share, Class B common stock (in Dollars per share) | $ / shares | $ 0.15 |
Statements of Changes in Stockh
Statements of Changes in Stockholders’ Deficit - 12 months ended Dec. 31, 2021 - USD ($) | Class ACommon Stock | Class BCommon Stock | Additional Paid-In Capital | Retained Earnings (Accumulated Deficit) | Total |
Balance at Dec. 31, 2020 | |||||
Balance (in Shares) at Dec. 31, 2020 | |||||
Issuance of Class B common stock to Sponsor | $ 575 | 24,425 | 25,000 | ||
Issuance of Class B common stock to Sponsor (in Shares) | 5,750,000 | ||||
Excess cash received over the fair value of the private warrants | 515,738 | 515,738 | |||
Forfeiture of Class B common stock | $ (19) | 19 | |||
Forfeiture of Class B common stock (in Shares) | (191,578) | ||||
Accretion of Class A common stock subject to possible redemption amount | (540,182) | (19,462,251) | (20,002,433) | ||
Net income | 3,503,074 | 3,503,074 | |||
Balance at Dec. 31, 2021 | $ 556 | $ (15,959,177) | $ (15,958,621) | ||
Balance (in Shares) at Dec. 31, 2021 | 5,558,422 |
Statement of Cash Flows
Statement of Cash Flows | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Cash Flows from Operating Activities: | |
Net income | $ 3,503,074 |
Adjustments to reconcile net income to net cash used in operating activities: | |
Net income from investments held in Trust Account | (43,721) |
Change in fair value of derivative warrant liabilities | (4,940,730) |
Offering cost - derivative warrant liabilities | 455,643 |
Changes in operating assets and liabilities: | |
Prepaid expenses | (378,247) |
Accounts payable | 165,909 |
Accrued expenses | 41,216 |
Franchise tax payable | 200,000 |
Due to related party | 15,000 |
Net cash used in operating activities | (981,856) |
Cash Flows from Investing Activities | |
Cash deposited in Trust Account | (222,336,870) |
Net cash used in investing activities | (222,336,870) |
Cash Flows from Financing Activities: | |
Proceeds from note payable to related party | 100,000 |
Repayment of note payable to related party | (100,000) |
Proceeds received from initial public offering, gross | 222,336,870 |
Proceeds received from private placement | 6,446,738 |
Offering costs paid | (4,880,666) |
Net cash provided by financing activities | 223,902,942 |
Net increase in cash | 584,216 |
Cash - beginning of the period | |
Cash - end of the period | 584,216 |
Supplemental disclosure of noncash activities: | |
Offering costs paid by Sponsor in exchange for issuance of Class B common stock | 25,000 |
Offering costs included in accrued expenses | 100,000 |
Deferred underwriting commissions in connection with the initial public offering | $ 7,781,790 |
Description of Organization and
Description of Organization and Business Operations | 12 Months Ended |
Dec. 31, 2021 | |
Description of Organization Business Operations and Liquidity [Abstarct] | |
Description of Organization and Business Operations | Note 1 - Description of Organization and Business Operations Organization and General FAST Acquisition Corp. II (the “Company”) is a blank check company incorporated in Delaware on December 30, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of December 31, 2021, the Company had not commenced any operations. All activity for the period from December 30, 2020 (inception) through December 31, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company’s sponsor is FAST Sponsor II LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on March 15, 2021. On March 18, 2021, the Company consummated its Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $200.0 million, and incurring offering costs of approximately $11.6 million, inclusive of $7.0 million in deferred underwriting commissions (see Note 5). The Company granted the underwriter in the Initial Public Offering (the “underwriter”) a 45-day option to purchase up to 3,000,000 additional units at the Initial Public Offering price to cover over-allotments, if any. The underwriter exercised the over-allotment option in part and, on March 26, 2021, the Company consummated the sale of additional 2,233,687 units at the Initial Public Offering price at $10.00 per Unit, generating additional gross proceeds of approximately $22.3 million (the “Over-Allotment”), and incurring additional offering costs of approximately $1.2 million, inclusive of approximately $0.8 million in deferred underwriting commissions. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,000,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $6.0 million (see Note 4). The Company consummated a second closing (the “Second Closing”) of the Private Placement simultaneously with the closing of the Over-Allotment on March 26, 2021, for an additional 297,825 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, generating proceeds of approximately $0.4 million. Upon the closing of the Initial Public Offering, the Over-Allotment and the Private Placement, $222.3 million ($10.00 per Unit) of the net proceeds were placed in a trust account (“Trust Account”) located in the United States at JP Morgan Chase Bank, N.A. with Continental Stock Transfer & Trust Company acting as trustee, and are invested only in U.S. “government securities,” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in Trust) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders (the “Public Stockholders”) of the Company’s Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, subject to applicable law and stock exchange listing requirements. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (at $10.00 per Public Share). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 5). These Public Shares were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination only if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination or don’t vote at all. In addition, the initial stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. The Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors (the “initial stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the initial Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or March 18, 2023 (as such period may be extended by the Company’s stockholders in accordance with the Certificate of Incorporation, the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The initial stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter agreed to waive its rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 or potentially less. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) not will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of December 31, 2021, the Company had approximately $584,000 in its operating bank account and working capital of approximately $440,000. The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the payment of $25,000 from the Sponsor to cover for certain offering costs on the Company’s behalf in exchange for issuance of Founder Shares (as defined in Note 4), and loan proceeds from the Sponsor of $100,000 under the Promissory Note (the “Note”). The Company repaid the Note in full upon closing of the Initial Public Offering. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company’s Working Capital Loans (as defined in Note 4). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loan. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC 205-40, “Basis of Presentation – Going Concern,” management has determined that mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 18, 2023. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. There was no activity as of the Company’s inception date of December 30, 2020, therefore financial statements for the period ended December 31, 2020 have not been included in this report. Restatement of Previously Filed Balance Sheet In preparation of the Company’s financial statements as of and for quarterly period ended December 31, 2021, the Company concluded it should restate its previously issued financial statement that reported in the Company’s Form 8-K filed with the SEC on March 24, 2021 (the “Post-IPO Balance Sheet”) to classify all Class A common stock subject to redemption in temporary equity and to classify its outstanding warrants as liabilities. In accordance with ASC 480-10-S99, redemption provisions not solely within the control of the Company require shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Class A common stock in permanent equity. Although the Company did not specify a maximum redemption threshold, its charter currently provides that the Company will not redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. The Company had previously classified a portion of its Class A common stock in permanent equity to maintain tangible assets at $5,000,001. The Company’s management re-evaluated the approach and determined that the redeemable Class A common stock included certain provisions that require classification of the Class A common stock as temporary equity regardless of the minimum net tangible assets required to complete the Company’s initial business combination. Accordingly, the Company determined it should present all redeemable Class A common stock as temporary equity and recognize accretion from the initial book value to redemption value at the time of the Initial Public Offering and Over-Allotment in accordance with ASC 480. Additionally, the Company reevaluated the accounting treatment of (i) the 5,558,422 redeemable warrants (the “Public Warrants”) that were included in the units issued by the Company in its Initial Public Offering and (ii) the 4,297,825 Private Placement Warrants that were issued to the Company’s sponsor in a private placement that closed concurrently with the closing of the Initial Public Offering (together with the Public Warrants, the “Warrants”). The Company previously classified the Warrants in stockholders’ equity. In further consideration of the guidance in FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”), the Company concluded that a provision in the warrant agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at inception (on the date of the Initial Public Offering) and at each subsequent reporting date, with changes in fair value recognized in income and losses. In accordance with FASB ASC Topic 340, “Other Assets and Deferred Costs,” as a result of the classification of the Warrants as derivative liabilities, the Company expensed a portion of the offering costs originally recorded as a reduction in equity. The portion of offering costs that was expensed was determined based on the relative fair value of the Public Warrants and Class A common stock included in the Units. In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company evaluated the corrections and has determined that the related impact was material to the Post-IPO Balance Sheet that contained the error. Therefore, the Company, in consultation with its Audit Committee, concluded that the Post-IPO Balance Sheet should be restated to present all outstanding Class A common stock subject to possible redemption as temporary equity, to recognize accretion from the initial book value to redemption value at the time of its Initial Public Offering, and to classify all outstanding Warrants as liabilities. As such, the Company is reporting these restatements to the audited March 18, 2021 balance sheet in this Form 10-K filing. The previously presented Post-IPO Balance Sheet should no longer be relied upon. The following tables summarize the impact of the restatement on each financial statement line item as of the date indicated: As of March 18, 2021 As Reported Adjustment As Restated Total assets $ 201,591,490 $ - $ 201,591,490 Derivative warrant liabilities - public warrants - 6,900,000 6,900,000 Derivative warrant liabilities - private warrants - 5,520,000 5,520,000 Total liabilities $ 7,168,694 $ 12,420,000 $ 19,588,694 Class A common stock subject to possible redemption 189,422,790 10,577,210 200,000,000 Preferred stock - - - Class A common stock 106 (106 ) - Class B common stock 575 - 575 Additional paid-in capital 5,042,601 (5,042,601 ) - Accumulated deficit (43,276 ) (17,954,503 ) (17,997,779 ) Total stockholders’ equity (deficit) $ 5,000,006 $ (22,997,210 ) (17,997,204 ) Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) $ 201,591,490 $ - $ 201,591,490 Number of Class A common stock subject to redemption 18,942,279 1,057,721 20,000,000 Number of non-redeemable Class A common stock 1,057,721 (1,057,721 ) - Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents held outside the Trust Account as of December 31, 2021. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” equal or approximate the carrying amounts represented in the balance sheet, except for the derivative warrant liabilities (See Note 8). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for the warrants issued in connection with its Initial Public Offering and the Private Placement Warrants as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liabilities may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the accompanying statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the Initial Public Offering and Over-Allotment. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Class A Common Stock Subject to Possible Redemption Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events, Accordingly, at December 31, 2021, 22,233,687 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including the exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount value, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December 31, 2021, the Company had deferred tax assets with a full valuation allowance against them. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Net Income (Loss) Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per share of common stock is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net income per share of common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 9,856,247 shares of common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events. The Company has considered the effect of Class B shares of common stock that were excluded from the weighted average number of basic shares outstanding as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company has included these shares in the weighted average number as of the beginning of the period to determine the dilutive impact of these shares. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The following table reflects the calculation of basic and diluted net income per share of common stock: December 31, 2021 Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income - basic $ 2,687,092 $ 815,982 Allocation of net income - diluted $ 2,662,402 $ 840,672 Denominator: Basic weighted average common shares outstanding 17,603,478 5,345,604 Effect of dilutive securities - 212,818 Diluted weighted average common shares outstanding 17,603,478 5,558,422 Basic net income per common share $ 0.15 $ 0.15 Diluted net income per common share $ 0.15 $ 0.15 Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statement. |
Initial Public Offering
Initial Public Offering | 12 Months Ended |
Dec. 31, 2021 | |
Initial Public Offering [Abstract] | |
Initial Public Offering | Note 3 - Initial Public Offering On March 18, 2021, the Company consummated its Initial Public Offering of 20,000,000 Units at $10.00 per Unit, generating gross proceeds of $200.0 million, and incurring offering costs of approximately $11.6 million, inclusive of $7.0 million in deferred underwriting commissions. Each Unit consists of one share of Class A common stock, and one-quarter of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). The Company granted the underwriter a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less underwriting discounts and commissions. The underwriter exercised the over-allotment option in part, and on March 26, 2021, purchased additional 2,233,687 units at the Initial Public Offering price at $10.00 per Unit, generating additional gross proceeds of approximately $22.3 million, and incurring additional offering costs of approximately $1.2 million, inclusive of approximately $0.8 million in deferred underwriting commissions. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2021 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 4 - Related Party Transactions Founder Shares On January 6, 2021, the Sponsor purchased 5,750,000 shares of the Company’s Class B common stock, par value $0.0001 per share, (the “Founder Shares”) for an aggregate price of $25,000. The initial stockholders agreed to forfeit up to 750,000 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriter, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On March 26, 2021, the underwriter exercised the option to purchase 2,233,687 additional units, for a total of 22,233,687 Units and forfeited 191,578 shares of Class B common stock. As of December 31, 2021, there were 5,558,422 shares of Class B common stock outstanding, none subject to forfeiture. The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (i) one year after the completion of the initial Business Combination and (ii) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property. Notwithstanding the foregoing, if (1) the last reported sales price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s stockholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from the lock-up. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 4,000,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $6.0 million. On March 26, 2021, the Sponsor purchased an additional 297,825 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a Second Closing, generating proceeds of approximately $0.4 million. Each whole Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On January 6, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to the Note. This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed $100,000 under the Note and repaid the Note in full upon closing of the Initial Public Offering. As of December 31, 2021, the loan was no longer available. In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lenders’ discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2021, the Company had no borrowings under the Working Capital Loans. Administrative Service Agreement Commencing on the date that the Company’s securities were first listed on the New York Stock Exchange and continuing until the earlier of the Company’s consummation of a Business Combination and the Company’s liquidation, to the Company agreed to pay the Sponsor a total of $15,000 per month for office space, utilities, secretarial and administrative support services provided to members of the Company’s management team. The Company incurred approximately $150,000 in administrative expenses under the agreement, which is recognized in the accompanying statement of operations for year ended December 31, 2021, within general and administrative expense - related party, respectively. As of December 31, 2021, $15,000 in accounts payable with related party was outstanding in the accompanying balance sheet. The Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers or directors, or their affiliates. |
Commitments & Contingencies
Commitments & Contingencies | 12 Months Ended |
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments & Contingencies | Note 5 - Commitments & Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares), were entitled to registration rights pursuant to a registration rights agreement. These holders were entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriter was entitled to an underwriting discount of $0.20 per unit, or $4.0 million in the aggregate, paid upon the closing of the Initial Public Offering. $0.35 per unit, or $7.0 million in the aggregate will be payable to the underwriter for deferred underwriting commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. In connection with the consummation of the Over-Allotment on March 26, 2021, the underwriter was entitled to an additional fee of approximately $447,000 paid upon closing, and an approximately $782,000 in deferred underwriting commissions. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and concludes that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target business, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. |
Common Stock Subject to Possibl
Common Stock Subject to Possible Redemption | 12 Months Ended |
Dec. 31, 2021 | |
Common Stock Subject To Possible Redemption [Abstract] | |
Common Stock Subject to Possible Redemption | Note 6 - Common Stock Subject to Possible Redemption The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 380,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of December 31, 2021, there were 22,233,687 shares of Class A common stock issued and outstanding, which were all subject to redemption and are classified outside of permanent equity in the balance sheet. Class A common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table: Gross proceeds $ 222,336,870 Less: Fair value of Public Warrants at issuance (7,670,620 ) Offering costs allocated to Class A common stock subject to possible redemption (12,331,812 ) Plus: Accretion of carrying value to redemption value 20,002,432 Class A common stock subject to possible redemption $ 222,336,870 |
Stockholders_ Deficit
Stockholders’ Deficit | 12 Months Ended |
Dec. 31, 2021 | |
Stockholders' Equity Note [Abstract] | |
Stockholders’ Deficit | Note 7 - Stockholders’ Deficit Preferred Stock Class A Common Stock Class B Common Stock Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of shares of Class A common stock and holders of shares of Class B common stock will vote together as a single class on all matters submitted to a vote of the stockholders except as required by law. The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by Public Stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. |
Warrants
Warrants | 12 Months Ended |
Dec. 31, 2021 | |
Warrants [Abstract] | |
Warrants | Note 8 – Warrants As of December 31, 2021, there were 5,558,422 Public Warrants and 4,297,825 Private Warrants outstanding. Public Warrants may only be exercised in whole and only for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60 th The warrants have an exercise price of $11.50 per share, subject to adjustments. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the Company’s initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash (except as described herein with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price (the “closing price”) of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The “fair market value” per share of Class A common stock for the above purpose shall mean the volume-weighted average price per share of Class A common stock during the ten trading days ending on the third trading day immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment). Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided ● if, and only if, the closing price of Class A common stock equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the closing price of Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 9 - Fair Value Measurements The following table presents information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Fair Value Measured as of December 31, 2021 Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account $ 222,380,591 $ - $ - $ 222,380,591 Liabilities: Derivative warrant liabilities - Public warrants 4,835,830 - - 4,835,830 Derivative warrant liabilities - Private warrants - - 3,825,060 3,825,060 Total fair value $ 227,216,421 $ - $ 3,825,060 $ 231,041,481 Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers during the period, except for the Derivative warrant liabilities - Public warrants which were transferred from Level 3 to Level 1 as they became separately listed and traded in May 2021. Level 1 assets include investment in money market funds that invest in U.S. Treasury Securities For periods where no observable traded price is available, the fair value of the Public Warrants and Private Placement Warrants has been estimated using a Monte-Carlo simulation to estimate the fair value of the warrants at each reporting period, with changes in fair value recognized in the statements of operations. The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, was determined using Level 3 inputs. For the year ended December 31, 2021, the Company recognized income of approximately $4.9 million from a decrease in the derivative warrant liabilities, presented as change in fair value of derivative warrant liabilities on the accompanying statement of operations. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. If factors or assumptions change, the estimated fair values could be materially different. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following table provides quantitative information regarding the Level 3 fair value measurements inputs at their measurement dates: As of Exercise price $ 11.50 Stock Price 9.72 Option term (in years) 5.75 Volatility 16 % Risk-free interest rate 1.33 % The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the year ended December 31, 2021, is summarized as follows: Derivative warrant liabilities at January 1, 2021 $ - Issuance of Public and Private Warrants 13,601,620 Transfer of Public Warrants to Level 1 measurement (7,503,870 ) Change in fair value of derivative warrant liabilities (2,272,690 ) Derivative warrant liabilities at December 31, 2021 $ 3,825,060 |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 10 — Income Taxes The Company’s taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative expenses are generally considered start-up costs and are not currently deductible. There was no income tax expense for the year ended December 31, 2021. The income tax provision (benefit) consists of the following for the year ended December 31, 2021: December 31, Current Federal $ - State - Deferred Federal (208,978 ) State - Valuation allowance 208,978 Income tax provision $ - The Company’s net deferred tax assets are as follows as of December 31, 2021: December 31, Deferred tax assets: Start-up/Organization costs $ 176,460 Net operating loss carryforwards 32,519 Total deferred tax assets 208,978 Valuation allowance (208,978 ) Deferred tax asset, net of allowance $ - In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. There were no unrecognized tax benefits as of December 31, 2021. No amounts were accrued for the payment of interest and penalties at December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. A reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) is as follows for the year ended December 31, 2021: December 31, Statutory Federal income tax rate 21.0 % Change in Valuation Allowance 6.0 % Change in fair value of derivative warrant liabilities (29.7 )% Offering cost - derivative warrant liabilities 2.7 % Income Taxes Benefit 0.0 % |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 11 - Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. Based upon this review, the Company did not identify any subsequent events that have occurred that would require adjustment or disclosures in the financial statements. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. There was no activity as of the Company’s inception date of December 30, 2020, therefore financial statements for the period ended December 31, 2020 have not been included in this report. |
Restatement of Previously Filed Balance Sheet | Restatement of Previously Filed Balance Sheet In preparation of the Company’s financial statements as of and for quarterly period ended December 31, 2021, the Company concluded it should restate its previously issued financial statement that reported in the Company’s Form 8-K filed with the SEC on March 24, 2021 (the “Post-IPO Balance Sheet”) to classify all Class A common stock subject to redemption in temporary equity and to classify its outstanding warrants as liabilities. In accordance with ASC 480-10-S99, redemption provisions not solely within the control of the Company require shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Class A common stock in permanent equity. Although the Company did not specify a maximum redemption threshold, its charter currently provides that the Company will not redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. The Company had previously classified a portion of its Class A common stock in permanent equity to maintain tangible assets at $5,000,001. The Company’s management re-evaluated the approach and determined that the redeemable Class A common stock included certain provisions that require classification of the Class A common stock as temporary equity regardless of the minimum net tangible assets required to complete the Company’s initial business combination. Accordingly, the Company determined it should present all redeemable Class A common stock as temporary equity and recognize accretion from the initial book value to redemption value at the time of the Initial Public Offering and Over-Allotment in accordance with ASC 480. Additionally, the Company reevaluated the accounting treatment of (i) the 5,558,422 redeemable warrants (the “Public Warrants”) that were included in the units issued by the Company in its Initial Public Offering and (ii) the 4,297,825 Private Placement Warrants that were issued to the Company’s sponsor in a private placement that closed concurrently with the closing of the Initial Public Offering (together with the Public Warrants, the “Warrants”). The Company previously classified the Warrants in stockholders’ equity. In further consideration of the guidance in FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”), the Company concluded that a provision in the warrant agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at inception (on the date of the Initial Public Offering) and at each subsequent reporting date, with changes in fair value recognized in income and losses. In accordance with FASB ASC Topic 340, “Other Assets and Deferred Costs,” as a result of the classification of the Warrants as derivative liabilities, the Company expensed a portion of the offering costs originally recorded as a reduction in equity. The portion of offering costs that was expensed was determined based on the relative fair value of the Public Warrants and Class A common stock included in the Units. In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company evaluated the corrections and has determined that the related impact was material to the Post-IPO Balance Sheet that contained the error. Therefore, the Company, in consultation with its Audit Committee, concluded that the Post-IPO Balance Sheet should be restated to present all outstanding Class A common stock subject to possible redemption as temporary equity, to recognize accretion from the initial book value to redemption value at the time of its Initial Public Offering, and to classify all outstanding Warrants as liabilities. As such, the Company is reporting these restatements to the audited March 18, 2021 balance sheet in this Form 10-K filing. The previously presented Post-IPO Balance Sheet should no longer be relied upon. The following tables summarize the impact of the restatement on each financial statement line item as of the date indicated: As of March 18, 2021 As Reported Adjustment As Restated Total assets $ 201,591,490 $ - $ 201,591,490 Derivative warrant liabilities - public warrants - 6,900,000 6,900,000 Derivative warrant liabilities - private warrants - 5,520,000 5,520,000 Total liabilities $ 7,168,694 $ 12,420,000 $ 19,588,694 Class A common stock subject to possible redemption 189,422,790 10,577,210 200,000,000 Preferred stock - - - Class A common stock 106 (106 ) - Class B common stock 575 - 575 Additional paid-in capital 5,042,601 (5,042,601 ) - Accumulated deficit (43,276 ) (17,954,503 ) (17,997,779 ) Total stockholders’ equity (deficit) $ 5,000,006 $ (22,997,210 ) (17,997,204 ) Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) $ 201,591,490 $ - $ 201,591,490 Number of Class A common stock subject to redemption 18,942,279 1,057,721 20,000,000 Number of non-redeemable Class A common stock 1,057,721 (1,057,721 ) - |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. As of December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents held outside the Trust Account as of December 31, 2021. |
Investments Held in Trust Account | Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” equal or approximate the carrying amounts represented in the balance sheet, except for the derivative warrant liabilities (See Note 8). |
Fair Value Measurement | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
Derivative Warrant Liabilities | Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The Company accounts for the warrants issued in connection with its Initial Public Offering and the Private Placement Warrants as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liabilities may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. |
Offering Costs Associated with the Initial Public Offering | Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the accompanying statement of operations. Offering costs associated with the Class A common stock issued were charged against the carrying value of the shares of Class A common stock upon the completion of the Initial Public Offering and Over-Allotment. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events, Accordingly, at December 31, 2021, 22,233,687 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including the exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount value, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of December 31, 2021, the Company had deferred tax assets with a full valuation allowance against them. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. |
Net Income (Loss) Per Share of Common Stock | Net Income (Loss) Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per share of common stock is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net income per share of common stock does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 9,856,247 shares of common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events. The Company has considered the effect of Class B shares of common stock that were excluded from the weighted average number of basic shares outstanding as they were contingent on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company has included these shares in the weighted average number as of the beginning of the period to determine the dilutive impact of these shares. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The following table reflects the calculation of basic and diluted net income per share of common stock: December 31, 2021 Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income - basic $ 2,687,092 $ 815,982 Allocation of net income - diluted $ 2,662,402 $ 840,672 Denominator: Basic weighted average common shares outstanding 17,603,478 5,345,604 Effect of dilutive securities - 212,818 Diluted weighted average common shares outstanding 17,603,478 5,558,422 Basic net income per common share $ 0.15 $ 0.15 Diluted net income per common share $ 0.15 $ 0.15 |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statement. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Schedule of summarize the impact of the restatement on each financial statement line item | As of March 18, 2021 As Reported Adjustment As Restated Total assets $ 201,591,490 $ - $ 201,591,490 Derivative warrant liabilities - public warrants - 6,900,000 6,900,000 Derivative warrant liabilities - private warrants - 5,520,000 5,520,000 Total liabilities $ 7,168,694 $ 12,420,000 $ 19,588,694 Class A common stock subject to possible redemption 189,422,790 10,577,210 200,000,000 Preferred stock - - - Class A common stock 106 (106 ) - Class B common stock 575 - 575 Additional paid-in capital 5,042,601 (5,042,601 ) - Accumulated deficit (43,276 ) (17,954,503 ) (17,997,779 ) Total stockholders’ equity (deficit) $ 5,000,006 $ (22,997,210 ) (17,997,204 ) Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit) $ 201,591,490 $ - $ 201,591,490 Number of Class A common stock subject to redemption 18,942,279 1,057,721 20,000,000 Number of non-redeemable Class A common stock 1,057,721 (1,057,721 ) - |
Schedule of calculation of basic and diluted net income per share | December 31, 2021 Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income - basic $ 2,687,092 $ 815,982 Allocation of net income - diluted $ 2,662,402 $ 840,672 Denominator: Basic weighted average common shares outstanding 17,603,478 5,345,604 Effect of dilutive securities - 212,818 Diluted weighted average common shares outstanding 17,603,478 5,558,422 Basic net income per common share $ 0.15 $ 0.15 Diluted net income per common share $ 0.15 $ 0.15 |
Common Stock Subject to Possi_2
Common Stock Subject to Possible Redemption (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Common Stock Subject To Possible Redemption [Abstract] | |
Schedule of Class A common stock subject to possible redemption reflected on condensed balance sheet | Gross proceeds $ 222,336,870 Less: Fair value of Public Warrants at issuance (7,670,620 ) Offering costs allocated to Class A common stock subject to possible redemption (12,331,812 ) Plus: Accretion of carrying value to redemption value 20,002,432 Class A common stock subject to possible redemption $ 222,336,870 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule o fair value on a recurring basfis | Fair Value Measured as of December 31, 2021 Level 1 Level 2 Level 3 Total Assets Investments held in Trust Account $ 222,380,591 $ - $ - $ 222,380,591 Liabilities: Derivative warrant liabilities - Public warrants 4,835,830 - - 4,835,830 Derivative warrant liabilities - Private warrants - - 3,825,060 3,825,060 Total fair value $ 227,216,421 $ - $ 3,825,060 $ 231,041,481 |
Schedule of Level 3 fair value measurements inputs at their measurement dates | As of Exercise price $ 11.50 Stock Price 9.72 Option term (in years) 5.75 Volatility 16 % Risk-free interest rate 1.33 % |
Schedule of change in the fair value of the derivative warrant liabilities measured with Level 3 inputs | Derivative warrant liabilities at January 1, 2021 $ - Issuance of Public and Private Warrants 13,601,620 Transfer of Public Warrants to Level 1 measurement (7,503,870 ) Change in fair value of derivative warrant liabilities (2,272,690 ) Derivative warrant liabilities at December 31, 2021 $ 3,825,060 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Schedule of income tax provision (benefit) | December 31, Current Federal $ - State - Deferred Federal (208,978 ) State - Valuation allowance 208,978 Income tax provision $ - |
Schedule of deferred tax assets | December 31, Deferred tax assets: Start-up/Organization costs $ 176,460 Net operating loss carryforwards 32,519 Total deferred tax assets 208,978 Valuation allowance (208,978 ) Deferred tax asset, net of allowance $ - |
Schedule of reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) | December 31, Statutory Federal income tax rate 21.0 % Change in Valuation Allowance 6.0 % Change in fair value of derivative warrant liabilities (29.7 )% Offering cost - derivative warrant liabilities 2.7 % Income Taxes Benefit 0.0 % |
Description of Organization a_2
Description of Organization and Business Operations (Details) - USD ($) | 1 Months Ended | 12 Months Ended | |
Mar. 26, 2021 | Mar. 18, 2021 | Dec. 31, 2021 | |
Description of Organization and Business Operations (Details) [Line Items] | |||
Sale of unit (in Shares) | 2,233,687 | ||
Price per unit (in Dollars per share) | $ 10 | ||
Generating gross proceeds | $ 22,300,000 | $ 222,336,870 | |
Deferred underwriting commissions | 800,000 | ||
Additional purchase units (in Shares) | 3,000,000 | ||
Deferred offering costs | $ 1,200,000 | ||
Net proceeds | $ 222,300,000 | ||
Intial held in trust account (in Dollars per share) | $ 10 | ||
Net tangible assets business combination | $ 5,000,001 | ||
Public share percentage | 15.00% | ||
Redemption of held in trust account percentage | 100.00% | ||
Dissolution expenses | $ 100,000 | ||
Residual assets remaining value per share (in Dollars per share) | $ 10 | ||
Share capital description | In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) not will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). | ||
Operating bank accounts | $ 584,000 | ||
working capital | 440,000 | ||
Sponsor [Member] | |||
Description of Organization and Business Operations (Details) [Line Items] | |||
Loan proceeds | $ 100,000 | ||
Business Acquisition [Member] | |||
Description of Organization and Business Operations (Details) [Line Items] | |||
Company's obligation to redeemed, percentage | 80.00% | ||
Percentage of outstanding voting securities | 50.00% | ||
IPO [Member] | |||
Description of Organization and Business Operations (Details) [Line Items] | |||
Sale of unit (in Shares) | 20,000,000 | ||
Price per unit (in Dollars per share) | $ 10 | $ 10 | |
Generating gross proceeds | $ 200,000,000 | ||
Offering costs | 11,600,000 | ||
Deferred underwriting commissions | 7,000,000 | ||
Offering costs | $ 25,000 | ||
Private Placement [Member] | |||
Description of Organization and Business Operations (Details) [Line Items] | |||
Price per unit (in Dollars per share) | $ 1.5 | $ 1.5 | |
Generating gross proceeds | $ 297,825 | ||
Offering costs | $ 11,600,000 | ||
Number warrants (in Shares) | 4,000,000 | ||
Generating proceeds (in Shares) | 400,000 | 6,000,000 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) | 12 Months Ended |
Dec. 31, 2021USD ($)shares | |
Summary of Significant Accounting Policies (Details) [Line Items] | |
Private placement warrants issued (in Shares) | shares | 4,297,825 |
Federal depository insurance corporation coverage | $ 250,000 |
Aggregate amount | 9,856,247 |
Business Combination [Member] | |
Summary of Significant Accounting Policies (Details) [Line Items] | |
Net tangible assets | $ 5,000,001 |
Public warrants [Member] | |
Summary of Significant Accounting Policies (Details) [Line Items] | |
Redeemable warrants (in Shares) | shares | 5,558,422 |
Class A Common Stock [Member] | |
Summary of Significant Accounting Policies (Details) [Line Items] | |
Permanent equity to maintain tangible assets | $ 5,000,001 |
Shares subject to possible redemption (in Shares) | shares | 22,233,687 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) - Schedule of summarize the impact of the restatement on each financial statement line item | 1 Months Ended |
Mar. 18, 2021USD ($)shares | |
As Reported [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Total assets | $ 201,591,490 |
Derivative warrant liabilities - public warrants | |
Derivative warrant liabilities - private warrants | |
Total liabilities | 7,168,694 |
Class A common stock subject to possible redemption | 189,422,790 |
Preferred stock | |
Additional paid-in capital | 5,042,601 |
Accumulated deficit | (43,276) |
Total stockholders' equity (deficit) | 5,000,006 |
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Equity (Deficit) | $ 201,591,490 |
Number of Class A common stock subject to redemption (in Shares) | shares | 18,942,279 |
Number of non-redeemable Class A common stock (in Shares) | shares | 1,057,721 |
As Reported [Member] | Class A Common Stock [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Common stock value | $ 106 |
As Reported [Member] | Class B Common Stock [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Common stock value | 575 |
Adjustment [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Total assets | |
Derivative warrant liabilities - public warrants | 6,900,000 |
Derivative warrant liabilities - private warrants | 5,520,000 |
Total liabilities | 12,420,000 |
Class A common stock subject to possible redemption | 10,577,210 |
Preferred stock | |
Additional paid-in capital | (5,042,601) |
Accumulated deficit | (17,954,503) |
Total stockholders' equity (deficit) | (22,997,210) |
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Equity (Deficit) | |
Number of Class A common stock subject to redemption (in Shares) | shares | 1,057,721 |
Number of non-redeemable Class A common stock (in Shares) | shares | (1,057,721) |
Adjustment [Member] | Class A Common Stock [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Common stock value | $ (106) |
Adjustment [Member] | Class B Common Stock [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Common stock value | |
As Restated [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Total assets | 201,591,490 |
Derivative warrant liabilities - public warrants | 6,900,000 |
Derivative warrant liabilities - private warrants | 5,520,000 |
Total liabilities | 19,588,694 |
Class A common stock subject to possible redemption | 200,000,000 |
Preferred stock | |
Additional paid-in capital | |
Accumulated deficit | (17,997,779) |
Total stockholders' equity (deficit) | (17,997,204) |
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Equity (Deficit) | $ 201,591,490 |
Number of Class A common stock subject to redemption (in Shares) | shares | 20,000,000 |
Number of non-redeemable Class A common stock (in Shares) | shares | |
As Restated [Member] | Class A Common Stock [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Common stock value | |
As Restated [Member] | Class B Common Stock [Member] | |
Condensed Balance Sheet Statements, Captions [Line Items] | |
Common stock value | $ 575 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Details) - Schedule of calculation of basic and diluted net income per share | 12 Months Ended |
Dec. 31, 2021USD ($)$ / sharesshares | |
Class A | |
Numerator: | |
Allocation of net income - basic (in Dollars) | $ | $ 2,687,092 |
Allocation of net income - diluted (in Dollars) | $ | $ 2,662,402 |
Denominator: | |
Basic weighted average common shares outstanding | 17,603,478 |
Effect of dilutive securities | |
Diluted weighted average common shares outstanding | 17,603,478 |
Basic net income per common share (in Dollars per share) | $ / shares | $ 0.15 |
Diluted net income per common share (in Dollars per share) | $ / shares | $ 0.15 |
Class B | |
Numerator: | |
Allocation of net income - basic (in Dollars) | $ | $ 815,982 |
Allocation of net income - diluted (in Dollars) | $ | $ 840,672 |
Denominator: | |
Basic weighted average common shares outstanding | 5,345,604 |
Effect of dilutive securities | 212,818 |
Diluted weighted average common shares outstanding | 5,558,422 |
Basic net income per common share (in Dollars per share) | $ / shares | $ 0.15 |
Diluted net income per common share (in Dollars per share) | $ / shares | $ 0.15 |
Initial Public Offering (Detail
Initial Public Offering (Details) - USD ($) | 1 Months Ended | 12 Months Ended | |
Mar. 26, 2021 | Mar. 18, 2021 | Dec. 31, 2021 | |
Initial Public Offering (Details) [Line Items] | |||
Sale of units (in Shares) | 20,000,000 | ||
Sale of stock per share (in Dollars per share) | $ 10 | ||
Generating gross proceeds | $ 22,300,000 | $ 222,336,870 | |
Deferred underwriting fees | $ 7,000,000 | ||
Initial public offering description | Each Unit consists of one share of Class A common stock, and one-quarter of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8) | ||
Purchase of additional shares (in Shares) | 3,000,000 | ||
Sale of Units (in Shares) | 2,233,687 | ||
Generating gross proceeds | $ 22,300,000 | ||
Deferred offering costs | 1,200,000 | ||
Deferred underwriting commissions | $ 800,000 | ||
Initial Public Offering [Member] | |||
Initial Public Offering (Details) [Line Items] | |||
Sale of stock per share (in Dollars per share) | $ 10 | $ 10 | |
Generating gross proceeds | $ 200,000,000 | ||
Other offering costs | 11,600,000 | ||
Deferred underwriting commissions | $ 7,000,000 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | Jan. 06, 2021 | Mar. 26, 2021 | Mar. 18, 2021 | Dec. 31, 2021 |
Related Party Transactions (Details) [Line Items] | ||||
Private placement warrants | 20,000,000 | |||
Underwriter exercised options to purchase additional units | 2,233,687 | |||
Initial business combination, description | (i) one year after the completion of the initial Business Combination and (ii) the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their common stock for cash, securities or other property. Notwithstanding the foregoing, if (1) the last reported sales price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s stockholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from the lock-up. | |||
Proceeds from warrants | $ 7,670,620 | |||
Sale of stock per share | $ 10 | |||
Note borrowed and repaid | $ 100,000 | |||
Working capital loan, description | The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lenders’ discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. | |||
Office space, utilities, secretarial and administrative support services | $ 15,000 | |||
Administrative expenses | 150,000 | |||
Accounts payable with related party | $ 15,000 | |||
Initial Public Offering [Member] | ||||
Related Party Transactions (Details) [Line Items] | ||||
Sale of stock per share | $ 10 | $ 10 | ||
Cover expenses | $ 300,000 | |||
Initial Public Offering [Member] | Founder Shares [Member] | ||||
Related Party Transactions (Details) [Line Items] | ||||
Issued and outstanding shares percentage | 20.00% | |||
Private Placement Warrants [Member] | ||||
Related Party Transactions (Details) [Line Items] | ||||
Private placement warrants | 297,825 | 4,000,000 | ||
Warrant price per share | $ 1.5 | $ 1.5 | ||
Proceeds from warrants | $ 400,000 | $ 6,000,000 | ||
Sale of stock per share | $ 11.5 | |||
Class B Common Stock [Member] | ||||
Related Party Transactions (Details) [Line Items] | ||||
Private placement warrants | 5,750,000 | |||
Common stock, par value | $ 0.0001 | $ 0.0001 | ||
Aggregate price | $ 25,000 | |||
Shares forfeited | 191,578 | |||
Additional units issued | 22,233,687 | |||
Common stock, shares outstanding | 5,558,422 | |||
Founder Shares [Member] | ||||
Related Party Transactions (Details) [Line Items] | ||||
Shares forfeited | 750,000 |
Commitments & Contingencies (De
Commitments & Contingencies (Details) - USD ($) | Mar. 26, 2021 | Dec. 31, 2021 |
Commitments & Contingencies (Details) [Line Items] | ||
Underwriting discount | $ 0.2 | |
Underwriting commission | $ 4,000,000 | |
Payable to the underwriters per share (in Dollars per share) | $ 0.35 | |
Underwriter additional fee | $ 7,000,000 | |
Over-Allotment Option [Member] | ||
Commitments & Contingencies (Details) [Line Items] | ||
Underwriting commission | $ 782,000 | |
Underwriter additional fee | $ 447,000 |
Common Stock Subject to Possi_3
Common Stock Subject to Possible Redemption (Details) - Class A Common Stock [Member] | 12 Months Ended |
Dec. 31, 2021$ / sharesshares | |
Common Stock Subject to Possible Redemption (Details) [Line Items] | |
Common stock shares authorized | 380,000,000 |
Common stock par value (in Dollars per share) | $ / shares | $ 0.0001 |
Common stock voting rights | one |
Shares subject to possible redemption | 22,233,687 |
Common Stock Subject to Possi_4
Common Stock Subject to Possible Redemption (Details) - Schedule of Class A common stock subject to possible redemption reflected on condensed balance sheet | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Schedule of Class A common stock subject to possible redemption reflected on condensed balance sheet [Abstract] | |
Gross proceeds | $ 222,336,870 |
Less: | |
Fair value of Public Warrants at issuance | (7,670,620) |
Offering costs allocated to Class A common stock subject to possible redemption | (12,331,812) |
Plus: | |
Accretion of carrying value to redemption value | 20,002,432 |
Class A common stock subject to possible redemption | $ 222,336,870 |
Stockholders_ Deficit (Details)
Stockholders’ Deficit (Details) - USD ($) | 1 Months Ended | 12 Months Ended | |
Mar. 26, 2021 | Dec. 31, 2021 | Jan. 06, 2021 | |
Stockholders’ Deficit (Details) [Line Items] | |||
Preferred stock, shares authorized | 1,000,000 | ||
Preferred stock, par value (in Dollars per share) | $ 0.0001 | ||
Forfeiture of Class B common stock (in Dollars) | |||
Business Acquisition [Member] | |||
Stockholders’ Deficit (Details) [Line Items] | |||
Business Combination Description | In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by Public Stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. | ||
Class A Common Stock [Member] | |||
Stockholders’ Deficit (Details) [Line Items] | |||
Common stock, shares authorized | 380,000,000 | ||
Common stock, par value (in Dollars per share) | $ 0.0001 | ||
Class B Common Stock [Member] | |||
Stockholders’ Deficit (Details) [Line Items] | |||
Common stock, shares authorized | 20,000,000 | ||
Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |
Additional shares | 2,233,687 | ||
Total units of shares | 22,233,687 | ||
Forfeiture of Class B common stock (in Dollars) | $ 191,578 | ||
Common stock, shares issued | 5,558,422 | ||
Common Stock, Shares, Outstanding | 5,558,422 |
Warrants (Details)
Warrants (Details) | 12 Months Ended |
Dec. 31, 2021$ / sharesshares | |
Warrants (Details) [Line Items] | |
Warrant exercise price | $ 11.5 |
Market value and newly issued price, per share percentage | 115.00% |
Redemption trigger price per share | $ 18 |
Description of redemption of warrants | Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash (except as described herein with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price (the “closing price”) of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The “fair market value” per share of Class A common stock for the above purpose shall mean the volume-weighted average price per share of Class A common stock during the ten trading days ending on the third trading day immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment). |
Redemption of warrants scenario two description | Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants, but only on a cashless basis, prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” per share of Class A common stock; ● if, and only if, the closing price of Class A common stock equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and ● if the closing price of Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. |
Business Acquisition [Member] | |
Warrants (Details) [Line Items] | |
Business combination effective issue price per share | $ 9.2 |
Total equity proceeds, percentage | 60.00% |
Warrant [Member] | |
Warrants (Details) [Line Items] | |
Market value and newly issued price, per share percentage | 180.00% |
Redemption trigger price per share | $ 10 |
Public warrants [Member] | |
Warrants (Details) [Line Items] | |
Shares issued (in Shares) | shares | 5,558,422 |
Private Warrants [Member] | |
Warrants (Details) [Line Items] | |
Shares issued (in Shares) | shares | 4,297,825 |
Class A Common Stock [Member] | |
Warrants (Details) [Line Items] | |
Equal exceeds of warrants | $ 18 |
Redemption of warrants | $ 10 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) | Dec. 31, 2021USD ($) |
Fair Value Disclosures [Abstract] | |
Cash | $ 1,100 |
Fair Value Measurements (Deta_2
Fair Value Measurements (Details) - Schedule of fair value on a recurring basis | Dec. 31, 2021USD ($) |
Assets | |
Investments held in Trust Account | $ 222,380,591 |
Liabilities: | |
Derivative warrant liabilities - Public warrants | 4,835,830 |
Derivative warrant liabilities - Private warrants | 3,825,060 |
Total fair value | 231,041,481 |
Level 1 [Member] | |
Assets | |
Investments held in Trust Account | 222,380,591 |
Liabilities: | |
Derivative warrant liabilities - Public warrants | 4,835,830 |
Derivative warrant liabilities - Private warrants | |
Total fair value | 227,216,421 |
Level 2 [Member] | |
Assets | |
Investments held in Trust Account | |
Liabilities: | |
Derivative warrant liabilities - Public warrants | |
Derivative warrant liabilities - Private warrants | |
Total fair value | |
Level 3 [Member] | |
Assets | |
Investments held in Trust Account | |
Liabilities: | |
Derivative warrant liabilities - Public warrants | |
Derivative warrant liabilities - Private warrants | 3,825,060 |
Total fair value | $ 3,825,060 |
Fair Value Measurements (Deta_3
Fair Value Measurements (Details) - Schedule of Level 3 fair value measurements inputs at their measurement dates | 12 Months Ended |
Dec. 31, 2021USD ($)$ / shares | |
Schedule of Level 3 fair value measurements inputs at their measurement dates [Abstract] | |
Exercise price (in Dollars per share) | $ / shares | $ 11.5 |
Stock Price (in Dollars) | $ | $ 9.72 |
Option term (in years) | 5 years 9 months |
Volatility | 16.00% |
Risk-free interest rate | 1.33% |
Fair Value Measurements (Deta_4
Fair Value Measurements (Details) - Schedule of change in the fair value of the derivative warrant liabilities measured with Level 3 inputs | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Schedule of change in the fair value of the derivative warrant liabilities measured with Level 3 inputs [Abstract] | |
Derivative warrant liabilities beginning balance | |
Issuance of Public and Private Warrants | 13,601,620 |
Transfer of Public Warrants to Level 1 measurement | (7,503,870) |
Change in fair value of derivative warrant liabilities | (2,272,690) |
Derivative warrant liabilities ending balance | $ 3,825,060 |
Income Taxes (Details) - Schedu
Income Taxes (Details) - Schedule of income tax provision (benefit) | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Current | |
Federal | |
State | |
Deferred | |
Federal | (208,978) |
State | |
Valuation allowance | 208,978 |
Income tax provision |
Income Taxes (Details) - Sche_2
Income Taxes (Details) - Schedule of deferred tax assets | Dec. 31, 2021USD ($) |
Deferred tax assets: | |
Start-up/Organization costs | $ 176,460 |
Net operating loss carryforwards | 32,519 |
Total deferred tax assets | 208,978 |
Valuation allowance | (208,978) |
Deferred tax asset, net of allowance |
Income Taxes (Details) - Sche_3
Income Taxes (Details) - Schedule of reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) | 12 Months Ended |
Dec. 31, 2021 | |
Schedule of reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) [Abstract] | |
Statutory Federal income tax rate | 21.00% |
Change in Valuation Allowance | 6.00% |
Change in fair value of derivative warrant liabilities | (29.70%) |
Offering cost - derivative warrant liabilities | 2.70% |
Income Taxes Benefit | 0.00% |